Vendor Intelligence Report: Henan Sahe Peptide

Published 3 Jul 2026. 27-page investigative report on who is behind Henan Sahe Peptide: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Across 45 Finnrick lab tests, Henan Sahe Peptide shows an 80% overall pass rate (36 pass / 8 fail), with Tirzepatide looking more defensible than Retatrutide under the current record. The full…